Herceptin Research Today is a free monthly online journal that collates and summarizes the latest research about Herceptin, including details on side-effects, breast cancer, treatment, therapy.

Volume 4 (2007), Issue 6 (June)

1. Potential benefit of maintenance trastuzumab and anastrozole therapy in male advanced breast cancer.
   Breast, 16(3): 323-5. [Abstract] [Full-text]
2. Improving quality of life after breast cancer: prevention of other diseases.
   Menopause Int, 13(2): 71-4. [Abstract] [Full-text]
3. In vivo therapeutic synergism of anti-epidermal growth factor receptor and anti-HER2 monoclonal antibodies against pancreatic carcinomas.
   Clin Cancer Res, 13(11): 3356-62. [Abstract] [Full-text]
4. Activation of AMP-activated protein kinase by human EGF receptor 2/EGF receptor tyrosine kinase inhibitor protects cardiac cells.
   Proc Natl Acad Sci U S A, 104(25): 10607-12. [Abstract] [Full-text]
5. Fluvastatin enhancement of trastuzumab and classical cytotoxic agents in defined breast cancer cell lines in vitro.
   Breast Cancer Res Treat, 104(1): 93-101. [Abstract] [Full-text]
6. Trastuzumab: mechanism of action, resistance and future perspectives in HER2-overexpressing breast cancer.
   Ann Oncol, 18(6): 977-84. [Abstract] [Full-text]
7. Clinical importance and therapeutic implications of the pivotal CXCL12-CXCR4 (chemokine ligand-receptor) interaction in cancer cell migration.
   Tumour Biol, 28(3): 123-31. [Abstract] [Full-text]
8. NK-cell and T-cell functions in patients with breast cancer: effects of surgery and adjuvant chemo- and radiotherapy.
   Br J Cancer, 97(1): 105-11. [Abstract] [Full-text]
9. HER2, TOP2A, CCND1, EGFR and C-MYC oncogene amplification in colorectal cancer.
   J Clin Pathol, 60(7): 768-72. [Abstract] [Full-text]
10. External quality assurance of HER2 fluorescence in situ hybridisation testing: results of a UK NEQAS pilot scheme.
    J Clin Pathol, 60(7): 816-9. [Abstract] [Full-text]

© 2004-2008 Herceptin Research Today. All Rights Reserved.